Obesity-induced inflammation exacerbates clonal hematopoiesis.

Area of Science:

• Hematology
• Genetics
• Immunology

Background:

• Clonal hematopoiesis of indeterminate potential (CHIP) involves somatic mutations in blood cells, increasing malignancy risk.
• CHIP is common in aging, but its risk factors, particularly obesity, are not well understood.
• Obesity creates inflammation and fatty bone marrow, potentially impacting CHIP progression.

Purpose of the Study:

• To investigate the association between obesity and CHIP.
• To explore the mechanisms linking obesity-induced inflammation to CHIP.
• To identify potential therapeutic targets for CHIP in obese individuals.

Main Methods:

• Analysis of exome sequencing and clinical data from 47,466 UK Biobank participants with CHIP.
• Utilized mouse models of obesity and CHIP (Tet2, Dnmt3a, Asxl1, Jak2 mutations).
• Evaluated the efficacy of calcium channel blockers and anti-inflammatory agents in vitro and in vivo.

Main Results:

• CHIP was identified in 5.8% of the study population and correlated with increased waist-to-hip ratio.
• Obesity and CHIP models showed exacerbated mutant hematopoietic stem and progenitor cell expansion due to inflammation.
• Specific drug combinations (e.g., nifedipine with metformin or anakinra) suppressed CHIP cell growth and restored hematopoiesis.

Conclusions:

• Obesity is strongly associated with CHIP and may potentiate its progression to hematologic neoplasia via inflammation.
• Targeting CHIP-mutant cells with specific drug combinations presents a potential therapeutic strategy for obese individuals with CHIP.
• Further research into the interplay between obesity, inflammation, and hematologic malignancies is warranted.